U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07687485) titled 'Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System' on June 26.
Brief Summary: The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Severe Tricuspid Valve Regurgitation
Intervention:
DEVICE: Transcatheter Tricuspid Valve Replacement (TTVR) with Laplace TTVR System
Transcatheter Tricuspid Valve Replacement
DEVICE: Transcatheter Tricus...